Hess Corp. (NYSE:HES): HES keeps rising with the price of oil. The stock was up to $86.46 against a 52-week low of $45.96.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN): BioMarin is now able to charge more for new drug Kuvan than expected. Shares were up to $37.17 compared to 52-week low of $15.53.
Savient Pharmaceuticals Inc. (NASDAQ:SVNT): Strong results from its new gout drug kept shares up second day in a row. It hit $19.40 against 52-week low of $10.58.
Rigel Pharmaceuticals Inc. (NASDAQ:RIGL): An upgrade from Lehman came after strong results from drug trials. Shares spiked to $31 in contrast to 52-week low of $6.64.
Douglas A. McIntyre is an editor at 247wallst.com.
Reid Hoffman: LinkedIn will go public (at some point)
Retailers can't wait for Black Friday, open Thursday
Tiffany's serves up solid quarterly earnings
